A US-based, leading generics pharmaceuticals company approached Freyr for Regulatory support in the compilation, evaluation, and submission of the Annual Report to the USFDA. Freyr’s team had to overcome challenges such as stringent timelines, validating and updating various documents, and ensuring compliance with the prevalent regulations. We were able to help the customer accomplish product compliance by optimizing our resources and time and ensuring product continuity in the US market.

Know more about how Freyr offered Regulatory support in the submission of the Annual Report to the USFDA by collaborating with multiple stakeholders to finalize the filing within the due date. Download the proven case.